Pathways related to antigen presentation via MHC class II in CD16- monocytes, especially HLA-DRA and CD4 interaction, might be associated with higher anti-SARS-CoV2-IgG level in RA patients. The gene discussed is CD4; the disease is rheumatoid arthritis.